Category: Disease Discoveries
-
Study Identifies New Therapeutic Target for Most Common Type of Pancreatic Cancer
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
-
New Regulator of Therapy Resistance in Prostate Cancer
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
-
New Regulator of Prostate Cancer Metastasis Discovered
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
-
New Tool to Create Hearing Cells Lost in Aging
Northwestern Medicine scientists have discovered a master gene that programs ear hair cells’ development, overcoming a major hurdle towards restoring hearing.
-
Almost Half of Heart Failure Patients Have Uncontrolled Hypertension and Diabetes
A new Northwestern Medicine study has found almost half of U.S. adults with heart failure have poorly controlled hypertension and diabetes.
-
Regulator of Cancer ‘Stemness’ Discovered
The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study.
-
Expanding HIV Science
In this feature story, Northwestern scientists share their work at the forefront of HIV research, pioneering new strategies to investigate, treat, and work towards a cure for the disease.
-
Epigenetic ‘Age’ Predicts Cognitive Function
Epigenetic markers of cognitive aging can predict outcomes on cognitive tests later in life, according to a recent Northwestern Medicine study.
-
Improving Interferon Therapy for Blood Cancers
Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular type of blood cancer, according to findings published in Nature Communications. Targeting this pathway in combination with interferon therapy may provide a novel approach to[…]
-
Improving Interferon Therapy for Blood Cancers
Investigators have discovered a novel signaling pathway in interferons that suppresses their anti-tumor response in patients with a particular type of blood cancer.
